ES2543629T3 - Células productoras de polipéptidos - Google Patents
Células productoras de polipéptidos Download PDFInfo
- Publication number
- ES2543629T3 ES2543629T3 ES10154684.4T ES10154684T ES2543629T3 ES 2543629 T3 ES2543629 T3 ES 2543629T3 ES 10154684 T ES10154684 T ES 10154684T ES 2543629 T3 ES2543629 T3 ES 2543629T3
- Authority
- ES
- Spain
- Prior art keywords
- immunoglobulin
- nucleic acid
- mrna
- domain
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Método de selección de una célula eucariótica expresante de una inmunoglobulina, en el que el método comprende: a) transfectar una célula eucariótica con un ácido nucleico que comprende, en dirección 5' a 3', i) un primer ácido nucleico codificante de por lo menos un fragmento de un dominio CH3 o CH4 de cadena pesada de inmunoglobulina sin codón de parada traduccional dentro del marco, ii) un segundo ácido nucleico que se inicia con el sitio 5' donante de procesamiento de un dominio CH3 o CH4 de cadena pesada de inmunoglobulina y que termina en el sitio 3' aceptor de procesamiento del exón M1 de dominio transmembranal de cadena pesada de inmunoglobulina posterior que comprende un codón de parada traduccional dentro del marco y una señal de poliadenilación, iii) un tercer ácido nucleico codificante de: iiia) por lo menos un fragmento de un dominio transmembranal de inmunoglobulina, b) cultivar dicha célula transfectada bajo condiciones adecuadas a la producción de pre-ARNm de dicho ácido nucleico, procesar dicho pre-ARNm, y traducción de dicho ARNm procesado en una inmunoglobulina, en la que dicha célula transfectada produce inmunoglobulina soluble e inmunoglobulina unida a membrana plasmática mediante procesamiento alternativo de dicho pre-ARNm y c) seleccionar una célula con inmunoglobulina unida a membrana plasmática que será la célula expresante de una inmunoglobulina.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06010146 | 2006-05-17 | ||
| EP06010146 | 2006-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2543629T3 true ES2543629T3 (es) | 2015-08-20 |
Family
ID=37076089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10154684.4T Active ES2543629T3 (es) | 2006-05-17 | 2007-05-15 | Células productoras de polipéptidos |
| ES07725230.2T Active ES2573027T3 (es) | 2006-05-17 | 2007-05-15 | Células productoras de polipéptido |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07725230.2T Active ES2573027T3 (es) | 2006-05-17 | 2007-05-15 | Células productoras de polipéptido |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8354516B2 (es) |
| EP (2) | EP2027273B1 (es) |
| JP (1) | JP4870208B2 (es) |
| KR (1) | KR101202498B1 (es) |
| CN (1) | CN101410525B (es) |
| AU (1) | AU2007251766B2 (es) |
| BR (1) | BRPI0712073B8 (es) |
| CA (1) | CA2651478C (es) |
| ES (2) | ES2543629T3 (es) |
| IL (1) | IL193721A (es) |
| MX (1) | MX2008013514A (es) |
| WO (1) | WO2007131774A1 (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2543629T3 (es) * | 2006-05-17 | 2015-08-20 | Hoffmann-La Roche Ag | Células productoras de polipéptidos |
| US7732195B2 (en) | 2006-11-01 | 2010-06-08 | Facet Biotech Corporation | Tethered vectors for cell surface immunoglobulin display |
| WO2009059235A2 (en) * | 2007-11-01 | 2009-05-07 | Facet Biotech Corporation | Immunoglobulin display vectors |
| AU2009286956B2 (en) * | 2008-08-28 | 2012-12-06 | Novartis Ag | Cell surface display of polypeptide isoforms by stop codon readthrough |
| CA2753814C (en) | 2009-02-27 | 2018-07-31 | Novartis Ag | Novel selection vectors and methods of selecting eukaryotic host cells |
| FR2944018B1 (fr) | 2009-04-02 | 2012-03-09 | Isp Investments Inc | Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant |
| FR2944017B1 (fr) * | 2009-04-02 | 2012-03-09 | Isp Investments Inc | Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant |
| FR2944016B1 (fr) | 2009-04-02 | 2012-03-09 | Isp Investments Inc | Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant |
| FR2944797B1 (fr) | 2009-04-23 | 2013-05-10 | Isp Investments Inc | Hydrolysats peptidiques activateurs du proteasome et compositions les contenant |
| FR2944798B1 (fr) | 2009-04-23 | 2013-05-10 | Isp Investments Inc | Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant |
| CN101875916B (zh) * | 2009-11-27 | 2013-04-17 | 西安交通大学 | 一种fgfr1高表达的重组hek293细胞及其应用 |
| KR102286389B1 (ko) | 2012-11-20 | 2021-08-05 | 노파르티스 아게 | 폴리펩티드를 고 수율로 발현하는 최적화 발현 카세트 |
| WO2014126254A1 (ja) * | 2013-02-18 | 2014-08-21 | 協和発酵キリン株式会社 | 膜結合型タンパク質発現ベクター |
| EP2970956A1 (en) | 2013-03-11 | 2016-01-20 | Novartis AG | Method of screening cell clones |
| WO2014171826A1 (en) | 2013-04-17 | 2014-10-23 | Stichting Vu-Vumc | Treatment of cognitive impairment in depressive disorders |
| EP3027646B1 (en) | 2013-07-31 | 2018-06-27 | Novartis AG | Novel selection vectors and methods of selecting eukaryotic host cells |
| SG11201604218RA (en) | 2013-12-20 | 2016-07-28 | Novartis Ag | Novel eukaryotic cells and methods for recombinantly expressing a product of interest |
| CA2934411C (en) | 2013-12-20 | 2022-05-03 | Novartis Ag | Novel eukaryotic cells and methods for recombinantly expressing a product of interest |
| MA39502A (fr) * | 2014-02-28 | 2015-09-03 | Glenmark Pharmaceuticals Sa | Constructions d'expression et méthodes de sélection des cellules hôtes exprimant des polypeptides |
| US11623950B2 (en) | 2015-07-09 | 2023-04-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Lentiviral vector expressing membrane-anchored or secreted antibody |
| GB2557123B (en) | 2015-07-31 | 2021-11-03 | Univ Minnesota | Modified cells and methods of therapy |
| JP6818134B2 (ja) * | 2016-09-29 | 2021-01-20 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ポリペプチド産生細胞を選択するための改善された方法 |
| GB2573406B (en) | 2016-10-18 | 2021-11-10 | Univ Minnesota | Tumor infiltrating lymphocytes and methods of therapy |
| JP2020530307A (ja) | 2017-06-30 | 2020-10-22 | インティマ・バイオサイエンス，インコーポレーテッド | 遺伝子治療のためのアデノ随伴ウイルスベクター |
| WO2019015677A1 (en) * | 2017-07-21 | 2019-01-24 | Beijing Biocytogen Co., Ltd | GENETICALLY MODIFIED IMMUNOGLOBULIN HEAVY CHAIN ANIMALS |
| CN107557367B (zh) * | 2017-09-08 | 2020-11-03 | 北京大学人民医院 | Ighg1基因突变体及其应用 |
| CA3168968A1 (en) * | 2020-02-25 | 2021-09-02 | Herbert Alexander GRAVES | Gene delivery system |
| KR20230117147A (ko) * | 2020-12-01 | 2023-08-07 | 에테하 쭈리히 | 대안적 프로모터를 포함하는 dna 작제물 |
| CN120865355A (zh) * | 2024-04-29 | 2025-10-31 | 苏州系统医学研究所 | 一种工程化改造gpi锚定信号肽、其融合蛋白及应用 |
| CN118420709B (zh) * | 2024-04-29 | 2025-02-14 | 南京鼓楼医院 | 靶向cd73的肿瘤抗原肽、疫苗及其制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| WO1992008796A1 (en) | 1990-11-13 | 1992-05-29 | Immunex Corporation | Bifunctional selectable fusion genes |
| IL104570A0 (en) * | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
| DK1196566T3 (da) | 1999-07-12 | 2006-06-06 | Genentech Inc | Ekspressionsvektorer og -metoder |
| AUPQ422399A0 (en) | 1999-11-24 | 1999-12-16 | University Of New South Wales, The | Method of screening transformed or transfected cells |
| IL136459A0 (en) * | 2000-05-30 | 2001-06-14 | Galim Galil Immunology Ltd | Antibody library |
| WO2002057423A2 (en) | 2001-01-16 | 2002-07-25 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| WO2003011020A1 (en) | 2001-07-30 | 2003-02-13 | Smithkline Beecham Corporation | Imaging marker transgenes |
| US7384744B2 (en) | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| EP1477805A1 (de) | 2003-05-12 | 2004-11-17 | ProBioGen AG | Verfahren zur Zellselektion |
| WO2005020924A2 (en) | 2003-08-29 | 2005-03-10 | Centocor, Inc. | A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| SI1673391T1 (sl) | 2003-10-16 | 2009-06-30 | Claude Negrier | Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov |
| AU2005222963B2 (en) * | 2004-03-15 | 2009-10-29 | Biogen Idec Ma Inc. | Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| ES2543629T3 (es) * | 2006-05-17 | 2015-08-20 | Hoffmann-La Roche Ag | Células productoras de polipéptidos |
-
2007
- 2007-05-15 ES ES10154684.4T patent/ES2543629T3/es active Active
- 2007-05-15 ES ES07725230.2T patent/ES2573027T3/es active Active
- 2007-05-15 MX MX2008013514A patent/MX2008013514A/es active IP Right Grant
- 2007-05-15 AU AU2007251766A patent/AU2007251766B2/en not_active Ceased
- 2007-05-15 CN CN2007800108283A patent/CN101410525B/zh not_active Expired - Fee Related
- 2007-05-15 EP EP07725230.2A patent/EP2027273B1/en not_active Not-in-force
- 2007-05-15 KR KR1020087027867A patent/KR101202498B1/ko not_active Expired - Fee Related
- 2007-05-15 CA CA2651478A patent/CA2651478C/en not_active Expired - Fee Related
- 2007-05-15 US US12/299,918 patent/US8354516B2/en not_active Expired - Fee Related
- 2007-05-15 EP EP20100154684 patent/EP2208792B1/en not_active Not-in-force
- 2007-05-15 WO PCT/EP2007/004313 patent/WO2007131774A1/en not_active Ceased
- 2007-05-15 JP JP2009510343A patent/JP4870208B2/ja not_active Expired - Fee Related
- 2007-05-15 BR BRPI0712073A patent/BRPI0712073B8/pt not_active IP Right Cessation
-
2008
- 2008-08-27 IL IL193721A patent/IL193721A/en active IP Right Grant
-
2012
- 2012-12-05 US US13/705,339 patent/US8541204B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8541204B2 (en) | 2013-09-24 |
| EP2208792B1 (en) | 2015-05-06 |
| EP2027273A1 (en) | 2009-02-25 |
| ES2573027T3 (es) | 2016-06-03 |
| IL193721A (en) | 2014-09-30 |
| US8354516B2 (en) | 2013-01-15 |
| US20090311725A1 (en) | 2009-12-17 |
| BRPI0712073B8 (pt) | 2021-05-25 |
| KR101202498B1 (ko) | 2012-11-16 |
| AU2007251766A1 (en) | 2007-11-22 |
| CA2651478A1 (en) | 2007-11-22 |
| US20130109058A1 (en) | 2013-05-02 |
| EP2208792A2 (en) | 2010-07-21 |
| CA2651478C (en) | 2015-02-03 |
| IL193721A0 (en) | 2011-08-01 |
| CN101410525A (zh) | 2009-04-15 |
| JP2009537124A (ja) | 2009-10-29 |
| EP2208792A3 (en) | 2010-10-27 |
| AU2007251766B2 (en) | 2013-06-20 |
| CN101410525B (zh) | 2012-09-05 |
| JP4870208B2 (ja) | 2012-02-08 |
| WO2007131774A1 (en) | 2007-11-22 |
| MX2008013514A (es) | 2008-10-28 |
| BRPI0712073A2 (pt) | 2012-03-06 |
| BRPI0712073B1 (pt) | 2019-11-12 |
| EP2027273B1 (en) | 2016-04-13 |
| KR20090003327A (ko) | 2009-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR083551A1 (es) | Metodo para la preparacion de lignina | |
| PH12015502813A1 (en) | Electrolytic enrichment method for heavy water | |
| MX350966B (es) | Celulas madre pluripotentes. | |
| ES2479542T1 (es) | Métodos y composiciones para su uso en terapias celulares | |
| DK1846974T3 (da) | Membran-elektrode samlinger til brændstofceller, deres fremstilling og anvendelse og brændstofceller indeholdende disse | |
| EP4299721A3 (en) | Organoids comprising isolated renal cells and uses thereof | |
| DK1654776T3 (da) | Membran-elektrode-enhed til elektrokemiske anordninger | |
| WO2008126350A1 (ja) | 膜－膜補強部材接合体、膜－触媒層接合体、膜－電極接合体、高分子電解質形燃料電池、及び膜－電極接合体の製造方法 | |
| MX340242B (es) | Proceso mejorado para el cultivo de celulas. | |
| BR112015012889A2 (pt) | células eletroquímicas alcalinas com combinação de eletrólito e separador | |
| ES2531411T3 (es) | Procedimiento para la conversión de gas natural en compuestos aromáticos con separación electroquímica de hidrógeno | |
| MY152003A (en) | Cell line, system and method for optical control of secondary messengers | |
| PT1166382E (pt) | Fabricacao de celulas de combustivel tubulares modulos de celulas de combustivel elementos basicos e membranas permutadoras de ioes | |
| WO2009100040A3 (en) | Cell lines expressing gaba receptor and methods using them | |
| BRPI0915980A2 (pt) | eletrólito compósito condutor de próton, conjunto de eletrodo de membrana, e, dispositivo eletroquímico. | |
| WO2009079456A3 (en) | Gender-specific separation of sperm cells and embryos | |
| WO2006034224A3 (en) | Carbon-polymer electrochemical systems and their fabrication using layer-by layer technology | |
| UY32220A (es) | Material vegetal, plantas y metodo para producir la planta que contiene propiedades alteradas de lignina | |
| EA201170024A1 (ru) | Способы получения высокой плотности жизнеспособных клеток в культуре клеток млекопитающих | |
| NO20081732L (no) | Cellekjerneoverforing | |
| WO2005007932A3 (de) | Photovoltaiksystem für die direkte wasserstofferzeugung und -sammlung | |
| AR069974A1 (es) | Procesos para la preparacion de isomaltooligosacarido-hidrogenado | |
| WO2008012648A3 (en) | Method for manufacturing hydrogen separation membrane fuel cell | |
| EA201390869A1 (ru) | Электролизер со спиральным впускным шлангом | |
| WO2009051101A1 (ja) | 燃料電池用隔膜 |